Atlas FDA

NIRXCELL COCR CORONARY STENT ON RX SYSTEM

FDA premarket approval P110004/S001 · decided 2013-12-19

Approval details

PMA number
P110004
Supplement
S001
Supplement type
Normal 180 Day Track
Supplement reason
Change Design/Components/Specifications/Material
Trade name
NIRXCELL COCR CORONARY STENT ON RX SYSTEM
Generic name
STENT, CORONARY
Applicant
Medinol, Ltd.
Date received
2013-02-22
Decision date
2013-12-19
Days to decision
300 days
Decision code
APPR
Product code
MAF
Advisory committee
Cardiovascular
Expedited review
No
Location
Tel-Aviv
Statement
APPROVAL FOR MODIFICATIONS TO THE STENT DELIVERY SYSTEM. THE DEVICE, AS MODIFIED, WILL BE MARKETED UNDER THE TRADE NAME NIRXCELL COCR CORONARY STENT ON RX SYSTEM AND IS INDICATED FOR IMPROVING CORONARY LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC ISCHEMIC HEART DISEASE ASSOCIATED WITH STENOTIC LESIONS IN DE NOVO NATIVE CORONARY ARTERIES (LENGTH ¿30MM) WITH A REFERENCE VESSEL DIAMETER OF 2.50MM TO 4.00MM.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Gallant PTCA Dilatation Catheter (K173581)Medinol, Ltd.2018-01-25
NC Gallant PTCA Catheter (K162434)Medinol, Ltd.2017-01-19
X-Suit NIR Biliary Metallic Stent (K150487)Medinol, Ltd.2016-02-12
MEDINOL X-SUIT NIR BILIARY METALLIC STENT (K081956)Medinol, Ltd.2009-01-09
NIR BILIARY STENT (K002130)Medinol, Ltd.2000-10-30
NIR BILIARY STENT (K973171)Medinol, Ltd.1998-11-13